Nanotechnology could help with prostate cancer treatment options
the ONA take:
Novel nanotechnology could help men with prostate cancer make better decisions in treatment options, a study published in PLUS One suggested.
Researchers from Northwestern University led by Vadim Backman, PhD, used an optical technique he pioneered called partical wave spectroscopic (PWS) microscopy. The technology is able to detect cell features as precise as 20 nanometers which would help to distinguish cells that would appear normal with standard microscopy techniques.
The researchers analyzed prostate tissue biopsies from two cohorts of men with prostate cancer. They found a dramatic increase in nano-architectural disorder in progressors as compared to non-progressors.
As the first study to use PWS microscopy to predict cancer prognosis, the authors stated that the technology could be effective in avoiding unnecessary aggressive treatment in men with prostate cancer, which could lead to adverse events.
Novel nanotechnology could help men with prostate cancer make better decisions in treatment options.
Sign Up for Free e-newsletters
- Leukemia Risk in Children, Maternal Use of Hormonal Contraception Linked in Population Study
- Molecular Features May Predict Response in Primary Pancreatic Cancer
- Medication, Vaccination Uptake Improved by Involving Pharmacists in Elder Cancer Care
- Commission Seeks Standardized Adverse Event Assessments in Hematologic Malignancies
- Chemoimmunotherapy prolongs PFS in metastatic triple-negative breast cancer
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Counseling Patients on Oral Chemotherapy
- Patients and Caregivers Worry About Cost of Cancer Care
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Head and Neck Cancer Survivors Have Increased Suicide Risk
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|